Introduction
Borna disease (BD) is a transmissible, progressive polioencephalomyelitis that primarily occurs in horses and sheep. Experimentally, a wide variety of animal species ranging from chickens to nonhuman primates have been infected with Borna disease virus (BDV), the aetiological agent of BD (Richt et al., 1992) . The genomes of two cell-adapted BDV-strains have been cloned and sequenced ; BDV has been shown to contain a nonsegmented negative-sense 8n9 kb single-stranded RNAgenome with complementary 3h and 5h termini . Subgenomic RNAs have been mapped to the viral genome and some of them found to undergo post-transcriptional modification by RNA splicing (Schneider et al., 1994 ; . These features indicate that BDV represents the prototype of a new family of animal viruses within the order Mononegavirales.
BDV replication in cells is associated with the presence of at least four virus-specific antigens with molecular masses of 18 (gp18), 24 (p24), 38\39 (p38) and 84 or 94 (gp57) kDa Author for correspondence : Ju$ rgen Richt.
Fax j4 641 99 38359. e-mail juergen.a.richt!vetmed.uni-giessen.de its efficient expression as a glutathione S-transferase (GST) fusion protein demonstrated that antibodies specific for the BDV p10 protein are induced in infected animals. In addition, we have produced monospecific antisera against the GST-p10 fusion protein in rabbits. This monospecific antiserum recognized the BDV p10 protein in brain cells of naturally and experimentally infected animals as well as in persistently BDV-infected cells. Antibodymediated affinity-chromatography using the antip10 serum could successfully be applied to purify a ca. 10 kDa antigen from infected animal cells to such an extent that glycosylation of this component could be ruled out. (Schneemann et al., 1995 ; Schneider et al., 1997 ; GonzalezDunia et al., 1997 ; J. A. Richt and others, unpublished) . Based on immunological analysis, it has been suggested that the 38 and 39 kDa polypeptides are closely related and presumably represent modified forms of the same protein (Haas et al., 1986 ; Bause-Niedrig et al., 1992) . The p24 protein appears to be a different, unrelated protein. Neither the p38 nor the p24 proteins are glycosylated and both are soluble proteins ; the p24 protein is phosphorylated (Thiedemann et al., 1992) . The gp18 protein is a membrane-associated glycoprotein with an unusual N-linked glycosylation pattern (Kliche et al., 1994) , which apparently contains epitopes important for virus neutralization (Hatalski et al., 1995) . The 84 (Gonzalez-Dunia et al., 1997 ; J. A. Richt and others, unpublished) or 94 kDa protein (Schneider et al., 1997) is heavily N-glycosylated, contains epitopes for virus neutralization and has been suggested to be important for virus entry.
Sequence analysis of the BDV genome suggested that an open reading frame (ORF), x1, overlaps ORF II and might encode a protein that would be expected to have a molecular mass of approximately 10 kDa (p10, Fig. 1 ; VandeWoude et al., 1990 ; Richt et al., 1991 ; . Here we report the cloning and expression of ORF x1 in E. coli as a fusion protein with glutathione S-transferase (GST-p10) and detection of this fusion protein by polyclonal BDV-specific antisera. Furthermore, we have produced a monospecific antiserum against the GST-p10 fusion protein in rabbits. This antiserum recognized the BDV p10 protein in brain cells of naturally or experimentally infected animals as well as persistently BDV-infected cell lines. In persistently infected MDCK cells the p10 protein was found mainly in the nucleus, colocalized with the intranuclear p38 protein. Antibodymediated affinity chromatography was used to purify the p10 protein from persistently infected cell lines and brain tissue from infected rats.
Methods

RT-PCR, cloning and expression of the p10 BDV-gene.
The open reading frame of the BDV p10 protein (nt 1182-1448 ; Pyper et al., 1993) was amplified from RNA isolated from BDV-infected rats using the following primers : 3h primer (anti-sense), 5h GCGGAATTC TCATCATTCGATAGCTGCTCCC 3h (EcoRI site at 5h end) ; 5h primer (sense), 5h ATAGGATCC ATGAGTTCCGACCTCCGGC 3h (BamHI site at 5h end).
RNA was isolated from BDV-infected rat brain using the standard acid guanidinium isothiocyanate-phenol-chloroform method (Chomczynski & Sacchi, 1987) ; 2 µg RNA was used for the RT reaction. The conditions for the RT reaction and for PCR were described previously . The amplified product was purified from agarose gels and cloned into the plasmid vector pGEX-2T (Pharmacia) after digestion with BamHI and EcoRI (Promega). The viral gene was fused to the GST gene of Schistosoma japonicum controlled by the tac promotor. The expression plasmid was transformed into competent E. coli Sure cells. Recombinant plasmids were analysed using restriction enzyme analysis and DNA sequencing. The DNA sequence of the cloned fragment (pGEX-p10) was identical to the sequence published by Pyper et al. (1993) .
Expression and purification of the BDV p10 protein in E. coli. E. coli containing pGEX-p10 was grown overnight in 100 ml of LB medium with 0n1 mg\ml ampicillin (Serva), then diluted in 1 litre of LB medium with ampicillin and grown to exponential phase (2-4 h). Expression of the GST-p10 fusion protein was induced with IPTG (0n1 mM ; Promega) for 4 h. The bacteria were pelleted by centrifugation (5900 g, 10 min, 4 mC), resuspended in PBS, and then lysed by sonication on ice ; cell debris was removed by centrifugation (9800 r.p.m., 10 min, 4 mC). The fusion protein in the supernatant was purified by binding to glutathione-Sepharose 4B (Pharmacia) following the manufacturer's instructions. The eluted fusion protein was dialysed against 1iPBS for 24 h at 4 mC, and then analysed by SDS-PAGE and immunoblot assays.
SDS-PAGE, Tricine-SDS-PAGE and Western blot analysis.
Ten µl volumes of GST-p10, GST, lysates of uninfected and BDVinfected human oligodendrocytes (Pauli & Ludwig, 1985) as well as uninfected and BDV-infected rat brain homogenates were mixed with Laemmli sample buffer (Laemmli, 1970) , heated for 2 min at 100 mC, and separated by SDS-PAGE on gels containing 12n5 % polyacrylamide. The separated proteins were transferred to nitrocellulose membranes by electroblotting. Polyclonal antisera from rabbits and rats and monospecific rabbit anti-p10 antiserum were diluted 1 : 100 in PBS containing 0n5% Tween 20. Nitrocellulose strips were incubated overnight at 4 mC with the respective diluted antisera. The strips were washed three times with PBS-0n5 % Tween 20 (washing buffer), and then biotinylated anti-species antibodies (Amersham) were added at a dilution of 1 : 1000. After three washes with washing buffer the nitrocellulose strips were incubated for 1 h with streptavidin-horseradish peroxidase (Amersham) diluted 1 : 2000 in washing buffer. Finally, the strips were washed three times in PBS and stained in a solution of 0n5 mg\ml 4-chloro-1-naphthol, 20 % (v\v) methanol and 0n4 µl\ml H # O # . Tricine-SDS-PAGE gels were used for the separation of the affinity purified proteins, since tricine allows the resolution of small proteins (Scha$ gger & von Jagow, 1987) .
The presence of carbohydrates on affinity-purified p10 protein was estimated with the ECL glycoprotein detection system (Amersham) according to the manufacturer's instructions.
Preparation of antisera. Polyvalent monospecific antisera were generated against the GST-p10 fusion protein in rabbit, and against the GST-p38 fusion protein in rat, immunized subcutaneously with 1 mg GST-p10 or 150 µg GST-p38 fusion protein in complete Freund's adjuvant. After 4 and 8 weeks the animals received a booster immunization with the same amount of antigen and were bled 1 week after the last immunization. The sera were tested for their reactivity in indirect immunofluorescence assays on BDV-infected and uninfected MDCK cells as well as by Western blot analysis with the respective fusion proteins.
Antibody-mediated affinity chromatography. The procedure has been described previously (Haas et al., 1986) . Briefly about 300 mg of protein was used per 10 ml of packed, activated Sepharose CL-6B conjugated with the gamma-globulin fraction of the monospecific rabbit anti-p10 serum. Bound protein was eluted with PBS-1 M NaClO % and the eluate was concentrated by centrifugation dialysis using Ultrafree-MC 10 kDa filters (Millipore).
Cells and antigen preparation. Persistently BDV-infected and uninfected MDCK cells were used for indirect immunofluorescence assay as previously described (Herzog & Rott, 1980) . ' Oligo ', a human oligodendrocyte cell line (Pauli & Ludwig, 1985 ; kindly provided by G. Pauli, Berlin, Germany) was infected with a retina-derived BDV strain from a naturally infected horse. To purify the BDV p10 protein, BDVinfected Oligo cells were washed with PBS and scraped from the bottom of the culture dish. The cell suspension was then sedimented, washed, and resuspended with PBS and sonicated three times for 10 s. The cell homogenate was centrifuged (5000 g, 10 min, 4 mC) and the supernatant passed through the p10-affinity column. The column was washed and eluted as described above. Similarly, a 10 % homogenate of a BDVinfected rat brain (BDV-strain 5\27\92) in TN buffer was stirred for 1 h at room temperature after the addition of 1 % Triton X-100 and 0n5% deoxycholate. The homogenate was centrifuged for 2 h at 30 000 r.p.m. in a Beckman 45 Ti rotor to remove cell debris. The supernatant was applied to the affinity column and processed as described above.
Histology and immunohistochemistry. Brains were removed from experimentally infected rats 35 days post-infection and from naturally infected horses which were euthanized at the peak of clinical symptoms. The tissues were fixed in 4 % formaldehyde and embedded in paraffin. All tissue sections were stained with haematoxylin and eosin. Immunohistological analysis was carried out with the p10-specific rabbit antiserum at a dilution of 1 : 500 in PBS. The reaction was carried out using the avidin-biotin complex (ABC) system (Vector Laboratories). As controls, brain samples from an uninfected rat and horse were treated and stained similarly.
Results
RT-PCR amplification of ORF x1 ; expression and purification of the GST-p10 fusion protein
In order to amplify ORF x1, RNA isolated from BDVinfected rat brain was amplified by RT-PCR using the sense and anti-sense primers described in Methods. A single amplification product of the expected size (266 bp) was obtained (data not shown). After purification, the amplified BDV gene was cloned into the plasmid vector pGEX-2T, fused to the GST gene. The size of the resulting GST-BDV fusion protein is expected to be ca. 35 kDa, where 26 kDa of the fusion protein represents the GST protein and ca. 9 kDa represents the BDV p10 protein.
A band with a molecular mass of ca. 35 kDa was detected (using a polyclonal antiserum from a BDV-infected rat) in immunoblots of E. coli lysates from cultures which had been induced with IPTG (Fig. 2 a, lane 4) or left untreated (Fig. 2 a,  lane 3) . In a lysate from E. coli transformed with the nonrecombinant pGEX-2T plasmid as a control, immunoblots did not reveal an equivalent band in the GST-p10 position (Fig. 2 a, lane 2) . Fig. 2 (b, d) demonstrates that the GST-p10 fusion protein could easily be detected by convalescent antisera from rat (Fig. 2 b) and rabbit (Fig. 2 d) . The absence of any reaction in samples from cultures producing the GST control protein (lanes 2 in Fig. 2 b-e) or after blotting with normal serum [with rat serum shown in Fig. 2 (c) and with rabbit serum shown in Fig. 2 (e) ] confirms the virus-specificity of the BDV p10 protein.
We further analysed whether the mRNA encoding ORF II (BDV p24 protein) and ORF x1 (BDV p10 protein) is posttranscriptionally modified by the cellular splicing machinery. A sense primer from the noncoding 5h region (primer F305 ; Richt et al., 1991) of the p10\p24-encoding 0n85 kb mRNA and the antisense 3h primer of the ORF x1 region was used for RT-PCR (Figs 1 and 3) . Only a single band was obtained, indicating that post-transcriptional splicing mechanisms are not involved in generation of the ORF x1 or ORF II BDVspecific mRNA (Fig. 3, lane 1) .
Detection of the p10 BDV-protein in persistently infected cells and tissues using monospecific antisera
Polyvalent monospecific rabbit antiserum against the GST-p10 fusion protein and rat antiserum against GST-p38 were produced as described in Methods and used to stain persistently BDV-infected MDCK cells, fixed in acetone for 30 min at k20 mC. Double immunofluorescence technique using DTAF-and TRITC-labelled secondary antibodies revealed that the p10 protein colocalizes in the nucleus of infected cells (Fig. 4 a) along with p38 (Fig. 4 b) , the putative nucleoprotein of BDV. Furthermore, brain sections of an experimentally BDVinfected rat (Fig. 5 b, c) and a naturally infected horse (Fig. 5 d) that had been euthanized at the stage of overt BD were incubated with the monospecific anti-p10 rabbit antiserum. In contrast to infected MDCK cells, there was a striking preponderance of p10 antigen in the cytoplasm of neurons in the CNS of the BDV-infected rat (Fig. 5 b, c) and horse (Fig. 5 d) . No trace of staining could be detected in the non-infected control specimen (Fig. 5 a) .
Purification of the BDV p10 protein
The results of the antibody-mediated purification of the BDV p10 protein from BDV-infected cells and rat brain are shown in Fig. 6 . Using homogenates from BDV-infected and uninfected cells (Fig. 6, lanes 2 and 3) or rat brain (Fig. 6 , lanes 8 and 9) a distinct band representing the BDV p10 protein was difficult to detect in the infected material. Therefore, infected and uninfected BDV-infected cells and rat brain homogenates were treated as described in Methods and applied to the antip10 antibody-coated affinity column. This resulted in the enrichment of a virus-specific protein with a molecular mass of approximately 10 kDa from BDV-infected cells (Fig. 6 , lane 4) and rat brain (Fig. 6, lane 10) . In contrast, similar treatment of uninfected material failed to result in the isolation of a 10 kDa protein band (data not shown). Using centrifugation dialysis, the 10 kDa BDV protein could be concentrated (Fig. 6, lane 5) .
The deduced amino acid sequence of the p10 protein predicts a potential N-linked glycosylation site (Pyper et al., 1993 ; . To investigate whether p10 was glycosylated we used a glycan detection kit on the immunoaffinity purified p10 protein. As shown in Fig. 7 we were unable to detect carbohydrate side-chains on the p10 protein.
Discussion
In this paper we report the bacterial expression and intracellular detection of a novel nonglycosylated BDV-specific protein with a molecular mass of approximately 10 kDa (BDV p10 protein) in cells and tissues.
Virus-specificity of this product was supported by the detection of the 35 kDa GST-p10 fusion protein with antisera from infected animals and the absence of any reaction in samples from cultures producing the GST control protein or after contact with normal serum. Antibody-mediated affinity chromatography using the anti-fusion protein antiserum was successfully applied to enrich a 10 kDa antigen from infected animal cells. No carbohydrate-specific staining of the BDV p10 protein separated on PAGE gels was observed.
The absence of carbohydrate side-chains is in accordance with the intranuclear localization of the p10 protein in persistently BDV-infected MDCK cells ; in immuno-fluorescence experiments the distribution of p10 in the cell nucleus was similar to that demonstrated previously for the BDV p24 and p38 proteins (Haas et al., 1986 ; Thiedemann et al., 1992) . Double staining with anti-p10 and anti-p38 antibodies showed that p10 accumulated at the same sites in the nucleus of BDVinfected MDCK cells as p38. This finding suggests p10-p38 complex formation, which may be involved in the nuclear phase of virus replication (Briese et al., 1992) . In contrast, immunocytochemical studies using brain sections from naturally and experimentally BDV-infected animals indicated that the p10 protein is also localized in the cytoplasm of infected neurons (Fig. 5 c) . This has a parallel in the p38 nucleoprotein of BDV, which is found mainly in the nucleus of persistently BDV-infected MDCK cells, but also has a cytoplasmic distribution in infected brain cells (data not shown). Whether the intracellular localization of the BDV p10 protein depends on the cell type infected with BDV and\or the time after infection remains to be determined.
The p10 protein is encoded by a viral mRNA of ca. 0n85 kb which seems to be the smallest BDV-specific mRNA found in infected cells and tissues ( Fig. 1 ; VandeWoude et al., 1990 ; Richt et al., 1991 ; Briese et al., 1994 ; de la Torre, 1994) . The 0n85 kb mRNA contains two overlapping ORFs (ORF II and ORF x1) and can potentially code for proteins with calculated molecular masses of 9n5 (ORF x1) or 23n5 (ORF II) kDa. The latter ORF was found to encode the BDV-specific p24 protein by microsequencing of purified BDV p24 antigen (Thierer et al., 1992) . The findings reported here resolve doubts as to whether ORF x1 can code for a BDVspecific gene product with the proposed molecular mass of ca. 10 kDa.
In this report we clearly show that the ORF x1 codes for a 10 kDa protein, which is expressed and translated in BDVinfected tissues. The question of whether the p10\p24-encoding 0n85 kb mRNA exists as a bicistronic mRNA or a mRNA which is post-transcriptionally modified, was further investigated. There was no evidence for splicing of the 0n85 kb mRNA in our RT-PCR analyses using RNA from BDVinfected rat brain (Fig. 3) . Also, cloning and sequencing of the respective RT-PCR product did not reveal RNA splicing (data not shown). This result supports the proposal that the majority of BDV-specific mRNAs are of bi-, tri-or polycistronic nature, some of them being processed by the cellular splicing machinery (de la Torre, 1994 ; Schneemann et al., 1995) . Only the mRNA encoding the BDV p38 antigen seems to be monocistronic.
